In Vitro Effects of Carbenicillin Combined with Gentamicin or Polymyxin B Against Pseudomonas Aeruginosa

Overview

Journal Appl Microbiol

Publisher American Society for Microbiology

Specialty Microbiology

Date 1969 Sep 1

PMID 4313764

Citations 19

Authors

T C Eickhoff

Affiliations

Soon will be listed here.

Abstract

Disodium carbenicillin and gentamicin sulfate have both shown promise in the treatment of infections caused by Pseudomonas aeruginosa. This study was designed to explore possible synergistic relationships among the new as well as the established antimicrobial agents used to treat such infections. With an agar dilution technique, minimum inhibitory concentrations of 27 strains of P. aeruginosa were determined in two-dimensional tests. Graphs of equal biological activity (isobolograms) demonstrated moderate synergistic effects of the carbenicillin-gentamicin combination over therapeutically feasible concentration ranges. In contrast, the combination of carbenicillin and polymyxin B showed only additive or slightly antagonistic effects. Tests of bacterial killing confirmed the presence of carbenicillin-gentamicin synergy in 3 of 6 strains of P. aeruginosa, but did not show true antagonism between carbenicillin and polymyxin B. Clinical trials of both drug combinations are advisable to determine whether therapeutic results can be improved, and whether the dosages of gentamicin or polymyxin B can thereby be reduced to lessen their toxic hazards.

Citing Articles

Glucose-6-phosphate Reduces Fosfomycin Activity Against .

Gil-Gil T, Luis Martinez J Front Microbiol. 2022; 13:863635.

PMID: 35620111 PMC: 9127766. DOI: 10.3389/fmicb.2022.863635.

Synergy between cephalosporin and aminoglycoside antibiotics against Providencia and Proteus.

Hyams P, Simberkoff M, Rahal Jr J Antimicrob Agents Chemother. 1974; 5(6):571-7.

PMID: 15825407 PMC: 429016. DOI: 10.1128/AAC.5.6.571.

Antagonism of ampicillin and chloramphenicol for meningeal isolates of group B streptococci.

Weeks J, Mason Jr E, Baker C Antimicrob Agents Chemother. 1981; 20(3):281-5.

PMID: 7030197 PMC: 181688. DOI: 10.1128/AAC.20.3.281.

Synergistic activities of fortimicin A and beta-lactam antibiotics against Pseudomonas aeruginosa.

Yamashita K, Kawabe H, Mitsuhashi S Antimicrob Agents Chemother. 1981; 20(1):33-7.

PMID: 6792980 PMC: 181628. DOI: 10.1128/AAC.20.1.33.

Carbenicillin and gentamicin in the treatment of Pseudomonas aeruginosa infection.

Yuce K, van Rooyen C Can Med Assoc J. 1971; 105(9):919-22.

PMID: 5004774 PMC: 1931712.

References

NORD N, Watanabe F, Parker R, Hoeprich P . Comparative acute toxicity of four drugs. A study of neomycin, gentamicin, kanamycin, and dihydrostreptomycin. Arch Intern Med. 1967; 119(5):493-502. View

Brumfitt W, Percival A, Leigh D . Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. Lancet. 1967; 1(7503):1289-93. DOI: 10.1016/s0140-6736(67)91590-5. View

Acred P, Brown D, KNUDSEN E, Rolinson G, Sutherland R . New semi-synthetic penicillin active against Pseudomonas pyocyanea. Nature. 1967; 215(5096):25-30. DOI: 10.1038/215025a0. View

Bodey G, Terrell L . In vitro activity of carbenicillin against gram-negative bacilli. J Bacteriol. 1968; 95(5):1587-90. PMC: 252180. DOI: 10.1128/jb.95.5.1587-1590.1968. View

Smith C, FINLAND M . Carbenicillin: activity in vitro and absorption and excretion in normal young men. Appl Microbiol. 1968; 16(11):1753-60. PMC: 547754. DOI: 10.1128/am.16.11.1753-1760.1968. View

Bell S, Smith D . Resistance of Pseudomonas aeruginosa to carbenicillin. Lancet. 1969; 1(7598):753-4. DOI: 10.1016/s0140-6736(69)91754-1. View

Smith C, DANS P, Wilfert J, FINLAND M . Use of gentamicin in combinations with other antibiotics. J Infect Dis. 1969; 119(4):370-7. DOI: 10.1093/infdis/119.4-5.370. View

Standiford H, Kind A, KIRBY W . Laboratory and clinical studies of carbenicillin against gram-negative bacilli. Antimicrob Agents Chemother (Bethesda). 1968; 8:286-91. View

Hugh R, Leifson E . The taxonomic significance of fermentative versus oxidative metabolism of carbohydrates by various gram negative bacteria. J Bacteriol. 1953; 66(1):24-6. PMC: 357086. DOI: 10.1128/jb.66.1.24-26.1953. View

10.

LOEWE S . The problem of synergism and antagonism of combined drugs. Arzneimittelforschung. 1953; 3(6):285-90. View

11.

Bulger R, SIDELL S, KIRBY W . LABORATORY AND CLINICAL STUDIES OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC. Ann Intern Med. 1963; 59:593-604. DOI: 10.7326/0003-4819-59-5-593. View

12.

Sutherland R, BATCHELOR F . SYNERGISTIC ACTIVITY OF PENICILLINS AGAINST PENICILLINASE-PRODUCING GRAM-NEGATIVE BACILLI. Nature. 1964; 201:868-9. DOI: 10.1038/201868a0. View

13.

BRAYTON R, Louria D . GENTAMICIN IN GRAM-NEGATIVE URINARY AND PULMONARY INFECTIONS. Arch Intern Med. 1964; 114:205-12. DOI: 10.1001/archinte.1964.03860080055004. View

14.

JAO R, JACKSON G . GENTAMICIN SULFATE, NEW ANTIBIOTIC AGAINST GRAM-NEGATIVE BACILLI. LABORATORY, PHARMACOLOGICAL, AND CLINICAL EVALUATION. JAMA. 1964; 189:817-22. DOI: 10.1001/jama.1964.03070110019004. View

15.

Klein J, Eickhoff T, FINLAND M . GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS. Am J Med Sci. 1964; 248:528-44. View

16.

Sabath L, ABRAHAM E . SYNERGISTIC ACTION OF PENICILLINS AND CEPHALOSPORINS AGAINST PSEUDOMONAS PYOCYANEA. Nature. 1964; 204:1066-9. DOI: 10.1038/2041066a0. View